Find information on thousands of medical conditions and prescription drugs.

Severe combined immunodeficiency

Severe Combined Immunodeficiency, or SCID, is a genetic disorder in which both "arms" (B cells and T cells) of the adaptive immune system are crippled, due to a defect in one of several possible genes. SCID is a severe form of heritable immunodeficiency. It is also known as the "bubble boy" disease because its victims are extremely vulnerable to infectious diseases and must live (if untreated) in a completely sterile environment. The most famous case is the boy David Vetter. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
Sabinas brittle hair...
Saccharopinuria
Sacral agenesis
Saethre-Chotzen syndrome
Salla disease
Salmonellosis
Sandhoff disease
Sanfilippo syndrome
Sarcoidosis
Say Meyer syndrome
Scabies
Scabiophobia
Scarlet fever
Schamberg disease...
Schistosomiasis
Schizencephaly
Schizophrenia
Schmitt Gillenwater Kelly...
Sciatica
Scimitar syndrome
Sciophobia
Scleroderma
Scrapie
Scurvy
Selachophobia
Selective mutism
Seminoma
Sensorineural hearing loss
Seplophobia
Sepsis
Septo-optic dysplasia
Serum sickness
Severe acute respiratory...
Severe combined...
Sezary syndrome
Sheehan syndrome
Shigellosis
Shingles
Shock
Short bowel syndrome
Short QT syndrome
Shprintzen syndrome
Shulman-Upshaw syndrome
Shwachman syndrome
Shwachman-Diamond syndrome
Shy-Drager syndrome
Sialidosis
Sickle-cell disease
Sickle-cell disease
Sickle-cell disease
Siderosis
Silicosis
Silver-Russell dwarfism
Sipple syndrome
Sirenomelia
Sjogren's syndrome
Sly syndrome
Smallpox
Smith-Magenis Syndrome
Sociophobia
Soft tissue sarcoma
Somniphobia
Sotos syndrome
Spasmodic dysphonia
Spasmodic torticollis
Spherocytosis
Sphingolipidosis
Spinal cord injury
Spinal muscular atrophy
Spinal shock
Spinal stenosis
Spinocerebellar ataxia
Splenic-flexure syndrome
Splenomegaly
Spondylitis
Spondyloepiphyseal...
Spondylometaphyseal...
Sporotrichosis
Squamous cell carcinoma
St. Anthony's fire
Stein-Leventhal syndrome
Stevens-Johnson syndrome
Stickler syndrome
Stiff man syndrome
Still's disease
Stomach cancer
Stomatitis
Strabismus
Strep throat
Strongyloidiasis
Strumpell-lorrain disease
Sturge-Weber syndrome
Subacute sclerosing...
Sudden infant death syndrome
Sugarman syndrome
Sweet syndrome
Swimmer's ear
Swyer syndrome
Sydenham's chorea
Syncope
Syndactyly
Syndrome X
Synovial osteochondromatosis
Synovial sarcoma
Synovitis
Syphilis
Syringomas
Syringomyelia
Systemic carnitine...
Systemic lupus erythematosus
Systemic mastocytosis
Systemic sclerosis
T
U
V
W
X
Y
Z
Medicines

SCID affects about 1 in 80,000 live births. These babies, if untreated, usually die within 1 year due to severe, recurrent infections. Chronic diarrhea, ear infections, recurrent Pneumocystis jiroveci pneumonia, and profuse oral candidiasis commonly occur. Treatment options are much improved since David Vetter, and living in a bubble is no longer necessary.

Types

IL-7 signalling pathway

Most cases of SCID are derived from mutations in the γc chain in the receptors for interleukins IL-2, IL-4, IL-7, IL-9 and IL-15. These interleukins and their receptors are involved in the development and differentiation of T and B cells. Deleterious mutations in the gamma-chain or in the JAK3 protein cause a form of SCID that is characterized by low numbers of T and NK cells, and presence of non-functional B cells.

The IL-2 receptor γ (IL-2Rγ) gene is located on the X chromosome and mutation of this gene causes X-linked SCID.

Janus kinase-3 (JAK3) is an enzyme that mediates transduction downstream of the γc signal. Mutation of its gene also causes SCID.

VDJ recombination

The manufacture of immunoglobulins requires recombinase enzymes derived from the recombination activating genes RAG-1 and RAG-2. These enzymes are involved in the first stage of VDJ recombination, the process by which segements of a B cell or T cell's DNA are rearranged to create a new T cell receptor or B cell receptor (and, in the B cell's case, the template for antibodies). Certain mutations of the RAG-1 or RAG-2 genes prevent VDJ recombination, causing SCID.

Adenosine deaminase

Another well-known form of SCID is caused by a defective enzyme, adenosine deaminase (ADA), necessary for the breakdown of purines. Lack of ADA causes accumulation of dGTP. This metabolite is toxic to lymphoid stem cells.

Detection

Standard testing of SCID is not performed for newborns due to the rarity of the disease and the cost of the testing. SCID can be detected by sequencing fetal DNA if a known history of the disease exists. Otherwise, SCID is not detected until about six months of age, usually indicated by recurrent infections. The delay in detection is due to the fact that newborns carry their mother's antibodies for the first few weeks of life and have not yet been exposed to any diseases.

Treatment

The most common treatment for SCID is bone marrow transplantation, which requires matched donors (a sibling is generally best). David Vetter, the original "bubble boy," endured several failed transplantations, and finally passed away because of an unscreened virus, Epstein-Barr, in his newly-transplanted bone marrow from his sister. Today, transplants done in the first three months of life have a high success rate.

Read more at Wikipedia.org


[List your site here Free!]


Help for kids with SCIDs - gene therapy for one type of severe combined immunodeficiency disease - 1993 - The Year in Science
From Discover, 1/1/94 by Kathy Svitil

SEVERE COMBINED IMMUNODEFICIENCY DISEASES, OR SCIDS, ARE A GROUP OF DEVASTATING GENETIC DISORDERS THAT AFFLICT ONE IN EVERY 100,000 BABIES. FOR ONE REASON OR ANOTHER--SEVERAL gene defects are at fault--these babies are eventually left without the T cells that normally coordinate the body's response to invaders, leaving them with no immune system to speak of. In the past such babies often died within a year, unable to cope with the simplest colds or ear infections. But recent advances in genetics have improved prospects for some of these children. In fact, in 1993 researchers dared to talk for the first time not merely of treating children with one form of the disease but even of curing them.

Children with this kind of SCID have a defect in the gene for an enzyme, made by T cells, called adenosine deaminase, or ADA. This enzyme breaks down chemicals that, though normally made by the body, can poison T cells is allowed to build up. In the mid-1980s physicians began injecting children who lack the enzyme with ADA derived from cows. But for the treatment to be effective, children have to receive twice-weekly injections for the rest of their life.

A better, more long-lasting solution, some researchers believe, would be to provide cells with a good copy of the ADA gene. A first shot at such gene therapy was tried in 1990 on two young girls from Ohio. Reseachers from the National Institutes of Health removed T cells from each girl, inserted a normal copy of the gene inside the cells, then reinjected the cells. The altered T cells began making ADA, and the girls regained immune function. Yet the therapy falls short of the ideal: T cells live only a few months, so the engineered cells must be routinely replaced. As a safety net, the girls are also injected with twice-weekly enzyme supplements.

Donald Kohn, director of the gene therapy program at Childrens Hospital in Los Angeles, thinks a still better approach might be to stick the ADA gene into the blood's stem cells--precursor cells that give rise to T cells and live essentially forever. That's what Kohn and his colleagues tried in three SCID newborns this past May and June. At the babies' delivery, doctors retrieved a small amount of

umbilical cord blood, which is known to be rich in stem cells, and rushed it to Kohn's lab. Using an antibody that targets stem cells, Kohn's team separated the desired cells from the rest of the blood. The researchers then grew the stem cells in a lab dish and inserted a normal version of the ADA gene inside them, using a retrovirus as a carrier.

"Retroviruses are very efficient gene delivery vehicles," explains Kohn. "Unlike most viruses, they insert their genetic material directly into the cell's own genes." There was a snag, though. Cord blood is unusual in that it contains two types of stem cells: "baby" cells, which are active at birth but die within six months, and "permanent" stem cells, the real McCoys, which are initially quiescent. Since retroviruses can enter only active cells, Kohn added growth factors to prod the permanent cells into a brief growth spurt. Finally, all the stem cells--each carrying, Kohn hopes, a payload of ADA genes--were injected back into the babies.

It's still too early to tell if the startegy worked--Kohn's team is just getting the first hints that permanent stem cells might be producing T cells. Kohn suspects that most of the babies' current T cells are still the residual effect of their baby stem cells. To boost these T cells, the babies are also getting ADA enzyme shots. "What we're waiting to see," Kohn says cautiously, "is whether the T cells made by the babies' mature stem cells have the ADA gene. Then if we can show that having the gene makes T cells work better, and if the number of T cells with the gene increases, we may stop giving the babies extra ADA." All that may be too much to hope for at the very first attempt. But if the babies can make enough of their own ADA not to need extra treatment, they'd essentially be cured.

COPYRIGHT 1994 Discover
COPYRIGHT 2004 Gale Group

Return to Severe combined immunodeficiency
Home Contact Resources Exchange Links ebay